article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I firmly believe the current downtrend in the industry is an overreaction to incredibly positive results from Compass Pathways 2b trial, which have clearly been misinterpreted. DENVER, Dec.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,

Safety 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Are The Most Common Conditions MMJ Is Prescribed For?

MMJ Recs

However, more research is needed to establish standardized treatment protocols and ensure the long-term safety and efficacy of medical marijuana in managing PTSD. Success stories abound, with individuals reporting decreased anxiety, improved sleep, and a better overall quality of life.

article thumbnail

Five Things to Know About Hemp-CBD in Pet Products

Canna Law Blog

This can include regulating things like appetite and digestion, motor control, sleep, and muscle and bone growth. When it comes to CBD the, research is limited but a small clinical trial at Colorado State University found that CBD oil reduced seizures in epileptic dogs meaning that it may have similar effects as found in humans.

Pets 58
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

321(v), because they are not generally recognized, among experts qualified by scientific training and experience to evaluate the safety and effectiveness of animal drugs, as safe and effective for use under the conditions prescribed, recommended, or suggested in the labeling. 360b, 360ccc, and 360ccc-l. Office of Compliance.

CBD 51
article thumbnail

Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims

Cannabis Law Report

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. In the circumstances, the court was not satisfied that an award for cannabis was reasonable. In rejecting the claim, the court cited Torchia v.